Richard Aplenc

PROMISE — Pediatric Rare-Tumor Observational MultI-Source Evidence Network

Food and Drug Administration · U01

Contact PI · $1.5M · Children's Hosp of Philadelphia

Cancer Clinical Epidemiology Training Grant

National Cancer Institute · T32

PI · $4.4M · University of Pennsylvania

Predicting and Monitoring for Cardiac Toxicity in Pediatric AML

National Heart, Lung, and Blood Institute · R01

Contact PI · $2.6M · Children's Hosp of Philadelphia

Database Harmonization for Creation and Validation of Outcome Assessments and Prediction Tools for Metachromatic Leukodystrophy (MLD)

National Institute of Neurological Disorders and Stroke · R61

PI · $1.9M · Children's Hosp of Philadelphia

Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia

Principal investigator · Active not recruiting · Phase 1, Phase 2

Center for International Blood and Marrow Transplant Research

Home Away From Home - Quality of Life Surveys

Principal investigator · Completed

Children's Hospital of Philadelphia

Home or Away From Home - Descriptive Interviews (Aim 2)

Principal investigator · Completed

Children's Hospital of Philadelphia

Home Away From Home - Medical Outcomes

Principal investigator · Completed

Children's Hospital of Philadelphia